120 related articles for article (PubMed ID: 18824308)
41. HPV genotyping linear assay test comparison in cervical cancer patients: implications for HPV prevalence and molecular epidemiology in a limited-resource area in Bandung, Indonesia.
Panigoro R; Susanto H; Novel SS; Hartini S; Sahiratmadja E
Asian Pac J Cancer Prev; 2013; 14(10):5843-7. PubMed ID: 24289587
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of HPV-16/18 genotypes and immediate histopathologic correlation results in a Chinese population with negative cytology and positive high-risk HPV testing.
Tao X; Zhang H; Li J; Zhang H; Xiao J; Zhang L; Zhou X; Sui L; Wang L; Zhao C
Cancer Cytopathol; 2019 Oct; 127(10):650-657. PubMed ID: 31532582
[TBL] [Abstract][Full Text] [Related]
43. Comparison of a Newly Developed HPV Genotyping Assay (Mojin HPV Kit) with Cobas 4800 HPV Test for Detection of High-Risk HPV in Specimens Collected in SurePath Solution.
Yang WW; Wang ZG; Chen GF; Shi JF; Chen J; Ma QH; Zhou J; Mao XD; Liu C; Yao XM
Clin Lab; 2018 Mar; 64(3):387-391. PubMed ID: 29739098
[TBL] [Abstract][Full Text] [Related]
44. Type-specific human papillomavirus DNA testing with the genotyping array: a comparison of cervical and vaginal sampling.
Twu NF; Yen MS; Lau HY; Chen YJ; Yu BK; Lin CY
Eur J Obstet Gynecol Reprod Biol; 2011 May; 156(1):96-100. PubMed ID: 21288625
[TBL] [Abstract][Full Text] [Related]
45. Analytical performance of Cervista HPV 16/18 genotyping test for cervical cytology samples.
Bartholomew DA; Luff RD; Quigley NB; Curtis M; Olson MC
J Clin Virol; 2011 May; 51(1):38-43. PubMed ID: 21376660
[TBL] [Abstract][Full Text] [Related]
46. Distribution of human papillomavirus types in women from Valencia, Spain, with abnormal cytology.
Garcia-García JA; Pérez-Vallés A; Martorell M; Gómez B; Gómez-Cabrero D; Soler F; Calabuig C
Acta Cytol; 2010; 54(2):159-64. PubMed ID: 20391971
[TBL] [Abstract][Full Text] [Related]
47. Development and validation of a new HPV genotyping assay based on next-generation sequencing.
Yi X; Zou J; Xu J; Liu T; Liu T; Hua S; Xi F; Nie X; Ye L; Luo Y; Xu L; Du H; Wu R; Yang L; Liu R; Yang B; Wang J; Belinson JL
Am J Clin Pathol; 2014 Jun; 141(6):796-804. PubMed ID: 24838323
[TBL] [Abstract][Full Text] [Related]
48. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
[TBL] [Abstract][Full Text] [Related]
49. Potential coverage of circulating HPV types by current and developing vaccines in a group of women in Bosnia and Herzegovina with abnormal Pap smears.
Salimović-Bešić I; Hukić M
Epidemiol Infect; 2015 Sep; 143(12):2604-12. PubMed ID: 25578155
[TBL] [Abstract][Full Text] [Related]
50. Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.
Söderlund-Strand A; Rymark P; Andersson P; Dillner J; Dillner L
J Clin Microbiol; 2005 Jul; 43(7):3260-6. PubMed ID: 16000445
[TBL] [Abstract][Full Text] [Related]
51. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study.
Stoler MH; Wright TC; Sharma A; Apple R; Gutekunst K; Wright TL;
Am J Clin Pathol; 2011 Mar; 135(3):468-75. PubMed ID: 21350104
[TBL] [Abstract][Full Text] [Related]
52. [Performance of combined liquid based cytology and HPV nucleic acid test for detecting cervical precancer among women attending screening].
Jiang MY; Feng RM; Wang L; Li TY; Zhang AA; Cui JF; Pan QJ; Zhang X; Liu ML; Gao F; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):750-756. PubMed ID: 30392339
[No Abstract] [Full Text] [Related]
53. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
[No Abstract] [Full Text] [Related]
54. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
55. Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial.
Cook DA; Mei W; Smith LW; van Niekerk DJ; Ceballos K; Franco EL; Coldman AJ; Ogilvie GS; Krajden M
BMC Cancer; 2015 Dec; 15():968. PubMed ID: 26674353
[TBL] [Abstract][Full Text] [Related]
56. HPV genotype distribution according to severity of cervical neoplasia using the Digene HPV genotyping LQ test.
Halfon P; Lindemann ML; Raimondo A; Ravet S; Camus C; Khiri H; Pénaranda G; Sideri M; Sandri MT
Arch Virol; 2013 Jun; 158(6):1143-9. PubMed ID: 23299934
[TBL] [Abstract][Full Text] [Related]
57. [High-risk HPV genotyping PCR testing as a means of cervical cancer and precancerous lesions early screening].
Ma L; Cong X; Bian M; Shi M; Wang X; Liu J; Liu H
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):246-52. PubMed ID: 26080934
[TBL] [Abstract][Full Text] [Related]
58. Comparison of the AMPLICOR human papillomavirus test and the hybrid capture 2 assay for detection of high-risk human papillomavirus in women with abnormal PAP smear.
De Francesco MA; Gargiulo F; Schreiber C; Ciravolo G; Salinaro F; Manca N
J Virol Methods; 2008 Jan; 147(1):10-7. PubMed ID: 17854914
[TBL] [Abstract][Full Text] [Related]
59. [Detection and genotyping of high-risk human papillomavirus in cervical specimens].
Chacón J; Sanz I; Rubio MD; de la Morena ML; Díaz E; Mateos ML; Baquero F
Enferm Infecc Microbiol Clin; 2007 May; 25(5):311-6. PubMed ID: 17504684
[TBL] [Abstract][Full Text] [Related]
60. Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.
Einstein MH; Martens MG; Garcia FA; Ferris DG; Mitchell AL; Day SP; Olson MC
Gynecol Oncol; 2010 Aug; 118(2):116-22. PubMed ID: 20488510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
